Applications of Nanovesicular Drug Delivery

Amit Kumar Nayak (M. Pharm, Ph.D) is currently working as Professor at School of Pharmaceutical Sciences,Siksha ‘O' Anusandhan (Deemed to be University), Odisha, India. He has earned his PhD from IFTM University, Moradabad, Uttar Pradesh, India. He has over 14 years of research experiences in the field of pharmaceutics, especially in the development and characterization of novel biopolymeric and nanostructured drug delivery systems. Till date, he has authored more than 138 research and review publications in various high-impact peer-reviewed journals and 135 book chapters. He has edited/authored 23 international books to his credit. Dr. Nayak has presented his research work at several conferences. He has received University Foundation Day Research Award, 2019 and 2022 by Biju Patnaik University of Technology, Odisha. Dr. Nayak is a life member of the Association of Pharmaceutical Teachers of India (APTI) and a registered pharmacist.Md Saquib Hasnain (Ph.D) is currently working as the Professor and Dean, Department of Pharmaceutical Technology, School of Health and Medical Sciences, Barasat, Kolkata, West Bengal, India. He has over 13 years of research experience in the field of drug delivery and pharmaceutical formulation analyses, especially systematic development and characterization of diverse nanostructured drug delivery systems, controlled release drug delivery systems, bioenhanced drug delivery systems, nanomaterials and nanocomposites employing Quality by Design approaches and many more. Till date he has authored over 100 publications in various high impact peer-reviewed journals, more than 100 book chapters and 30 books to his credit. He is also serving as the reviewer of several prestigious journals. Overall, he has earned a highly impressive publishing and cited record. He has also participated and presented his research work at over ten conferences in India, and abroad. He was also a member of scientific societies i.e., Royal Society of Chemistry, Great Britain, International Association of Environmental and Analytical Chemistry, Switzerland and Swiss Chemical Society, Switzerland. Tejraj M. Aminabhavi is presently working as the Director of Research at Centre for Energy and Environment, School of Advanced Sciences, KLE Technological University, Hubballi, Karnataka, India. He works in the area of membrane transport processes, molecular modeling of polymer surfaces, wastewater treatment technologies, drug delivery polymers and sustainable environmental engineering. Dr Vladimir P. Torchilin is a University Distinguished Professor of Pharmaceutical Sciences and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, Mass. He graduated from the Moscow University with MS in Chemistry, and also obtained there his Ph.D. and D.Sc. in Polymer Chemistry, Chemical Kinetics and Catalysis, and Chemistry of Physiologically Active Compounds in 1971 and 1980, respectively. In 1991 Dr. Torchilin joined Massachusetts General Hospital and Harvard Medical School as the Head of Chemistry Program, Center for Imaging and Pharmaceutical Research, and Associate Professor of Radiology. Since 1998 Dr. Torchilin is with Northeastern University. He was there the Chair of the Department of Pharmaceutical Sciences in 1998-2008. His main interests include drug delivery and targeting, nanomedicine, multifunctional and stimuli-sensitive pharmaceutical nanocarriers, biomedical polymers, experimental cancer therapy, cancer immunology, novel imaging agents. He has published more than 500 original papers, more than 250 reviews and book chapters, wrote and edited 13 books, and hold more than 40 patents.

• 1. Introduction to nanovesicular drug delivery therapeutics2. Targeting cellular and molecular mechanisms of nanovesicular systems to treat different diseases3. Nanovesicles for drug co-delivery4. Theranostic nanovesicles5. Nanovesicles for oral drug delivery6. Nanovesicles for ocular drug delivery7. Nanovesicles for nasal drug delivery8. Nanovesicles for transdermal drug delivery9. Nanovesicles for intravenous drug delivery10. Nanovesicles for target-specific drug delivery11. Nanovesicles for brain-targeting drug delivery12. Nanovesicles for tumor-targeting drug delivery13. Nanovesicles for hepatic-targeting drug delivery14. Nanovesicles for colon-targeting drug delivery15. Nanovesicles for delivery of NSAIDs16. Nanovesicles for delivery of CNS drugs17. Nanovesicles for delivery of cardiovascular drugs18. Nanovesicles for delivery of antibiotics19. Nanovesicles for delivery of antifungal drugs20. Nanovesicles for delivery of anticancer drugs21. Nanovesicles for delivery of antiviral drugs22. Nanovesicles for delivery of protein and peptide drugs23. Nanovesicles for delivery of siRNA24. Patented nanovesicles for delivery of drugs25. Regulatory considerations of nanovesicles for drug delivery uses26. Clinical trials of nanovesicles for drug delivery uses27. Challenges and future perspectives of nanovesicles for drug delivery uses